References:
Masquelier,
J. Plant extract with a proanthocyanidins content as a therapeutic agent having
radical scavenging effect and use thereof. U.S. Patent No. 4,698,360, 1987.
Masquelier, J. A lifetime devoted to OPC and Pycnogenols. Alfa Omega Editrice,
Pub., 1996.
Schwitters, B., Masquelier, J. OPC in practice. Alfa Omega Editrice,
Publishers, 1995.
Kilham, C., Masquelier, J. OPC: The miracle antioxidant.
Keats Publishing, Inc., 1997.
Barilla, J. et al. The nutrition superbook:
volume 1: the antioxidants. Keats Publishing, Inc., 1995.
Facino RM, et al.
Free radical scavenging action and anti-enzyme activities of procyanidines from
Vitis vinifera. A mechanism for their capillary protective action. Arzneimittelforschung,
44: 592-601, 1994.
Kuttan R, et al. Collagen treated with catechin becomes
resistant to the action of mammalian collagenase. Experientia, 37: 221-223, 1981.
Masquelier, J., et al. Stabilization du collagene par les oligomeres procyanidoliques.
Acta Therapeutica, 7:101-105, 1981.
Masquelier, J. Aspects pharmacologiques
nouveaux de certains flavonoides. A Vie Medical 12:1969.
Laparra, J., et al.
Etude pharmaco-cinetique des oligomers procyandoliques totaux du raisin. Acta
Therapeutica, 4, 1978.
Laparra, J., et al. Etude pharmacocinetique des oligomeres
flavonoliques. Plantes med et phyto, Tome XI, pp. 133-142, 1977.
Robert A.M.;
Groult, N.; Six, C.; Robert, L. Etude de l’action des oligomeres procyanidoliques
sur des cellules mesenchymateuses en culture. Ii l’attachment des fibres
elastiques aux cellules. (Study of the effect of procyanidolic oligomers on mesenchymal
cells in culture. Ii attachment of elastic fibers to the cells.) Pat Biol, (30)6:601-7,
1990.
Porter, Lawrence J., Wong Rosalind Y. Chan, Bock G. The molecular and
crystal structure of (+)-2,3-trans-3,4-trans-leucocyanidin [(2r,3s,+r)-(+)-3,3’,
4.4’, 5.7’-Hexahydroxyflavan] dihydrate, and comparison of its heterocyclic
ring conformation in solution and the solid state. Journal of the Chemical Society;
Perkin Transactions I 1985. pp. 1413-17.
Masquelier, J. Proanthocyanidins
et radicaux libres. 1985.
Uchida, S., et al. Condensed tannins scavenge active
oxygen free radicals. Med Sci Res, (15) 1987. pp. 831-832.
Ariga, T. Radical
scavenging action and its mode in procyanidins b-1 and b-3 from azuki beans to
peroxyl radicals. Agric Biol Chem, 54(10) 1990. pp. 2499-2504.
Da Silva, R.,
et. al. Radical scavenger capacity of different procyanidins from grape seeds.
Presented at a symposium, “Free radicals in biotechnology and medicine.”
Royal Society Of Chemistry, London January 1990, pp. 79-80.
Bauman, J., Wurm,
G., Bruchhausen, F. “Hemmung der prostagladinsynthetase durch flavonoide
und phenolderivate im vergleich nit deren 02 radikalfangereigenschaften”
Arch Pharm, (Weinheim) 313 (1980) pp. 330-337.
Lombard, J., et al. The brain
wellness plan. Kensington Pub. Corp., 1998.
Flesch M., et al., Effects of
red and white wine on endothelium-dependent vasorelaxation of rat aorta and human
coronary arteries. Am J Physiol 1998;275:1183-94.
Fitzpatrick, D.F., Fleming
R.C., Bing B, Maggi DA, O'Malley RM. Isolation and characterization of endothelium-dependent
vasorelaxing compounds from grape seeds. J Agr & Food Chem In press.
Fitzpatrick, D.F., Maggi D, Bing B, Coffey RG. Vasorelaxation, endothelium, and
wine. BioFactors 1997;6:455-459.
Fitzpatrick, D.F., Hirschfield SL, Ricci
T, Jantzen P, Coffey RG. Endothelium-dependent vasorelaxation caused by various
plant extracts. J Cardiovasc Pharmacol 1995;26:90-95.
Fitzpatrick, D.F.,
Hirschfield SL, Coffey RG. Endothelium-dependent vasorelaxing activity of wine
and other grape products. Amer J Physiol 1993;265:H774-H778.
Lincoln, J.,
Hoyle, C.H.V., Burnstock, G., Nitric oxide in health and disease. Cambridge University
Press, 1997.
Libby, P., Ridker, P.M., Maseri, A. Inflammation and atherosclerosis.
Circulation 2002 Mar 5; 105(9): 1135-43.
Lindahl, B. et al. Markers of myocardial
damage and inflammation in relation to long-term mortality in unstable coronary
artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery
Disease. N. Engl. J. Med. 2000 Oct 19; 343(16): 1139 47.
Mendall, M.A., et
al. In the largest study of its kind published to date, researchers report that
hospitalized heart patients who took antibiotics had a significantly lower risk
of returning to the hospital with severe chest pain within one year compared with
those on a placebo. Circulation: Journal of the American Heart Association, Aug.
20, 2002.
Ridker, P.M., Cushman, M., Stampfer, M.J., Tracy, R.P., Hennekens,
C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently
healthy men. N. Engl. J. Med. 1997 Apr 3; 336(14): 973-9.
Facino, R.M., et
al. Free radical scavenging action and anti-enzyme activities of procyanidines
from vitis vinifera. A mechanism for their capillary protective action. Arzneimittelforschung,
44: 592-601, 1994.
Kuttan, R., Donnelly, P.V., Di Ferrante, N. Collagen treated
with catechin becomes resistant to the action of mammalian collagenase. Experientia,
37: 221-223, 1981.
Masquelier, J. Procyanidolic oligomers. J Parums Cosm
Arom, 95: 89-97, 1990.
Tixier, J.M., et al. Evidence by in vivo and in vitro
studies that binding of pycnogenols to elastin affects its rate of degradation
by elastases. Biochem Pharmacol, 33: 3933-3939, 1984.
Kakegawa, H., et al.
Chem. Pharm. Bull. 33:5079, 1985.
Harmand, M.F., Blanquet, P. The fate of
total flavanolic oligomers extracted from ‘vitus vinifera l.’ in the
rat. European Journal of Drug Metabolism and Pharmaccokinetics. 1978, No. 1 pp.
15-30.
Delrieu, P., Ding J., Escande, B., Samain, D. Free-radical scavenging
activity of proanthocyanidolic oligomers encapsulated in glycospheres: an in vivo
and in vitro study. Cosmetology Department & S Biovectors, Ramonville St.
Agne France. pp. 1-9.
Meunier, M.T., Villie, F., et al. Inhibition of angiotensin
i converting enzyme by flavanolic compounds: in vitro and in vivo studies. Planta
Medica, May 26, 1986. pp. 12-15.
Barbier, A., et al. Activite angioprotectrice
des oligomeres procyanidolques chez l’animal-oedenme de la patte. Sanofi
Res Toul Cedex Fr, pp31-40.
Barbier, A., et al. Activite angioprotectrice
des oligomeres procyanidolques chez l’animal-activite aniagoniste vis-a-vis
des mediateurs de l’inflamation. Sanofi Res Toul Cedex Fr, pp. 31-40.
Dubos, C., Durst, G., Hugonot, H. Evolution de la resistance capillaire, spontanement
ou artificiellement diminuee par l’action d’une substance capillaro-toxique
chez des personnes agees--action benefique d’un agnet actif sur la micro-circulation:
l’Endotelon. Inform. Therapeut. 1980. pp. 302-305.
Dartenuc, J.Y., et
al. Resistance capillaire en geriatrie etude d’un microangioprotecteur-Endotelon.
Bordeaux Med. 13:903-7, 1990.
Lagrue, G., Olivier-Martin, F., Grillot, A.
“Etude des effets des oligomeres du procyanidol sur las resistance capillaire
dand l’hypertension arterielle et certaines nephropathies.” Sen. Hosp.
Paris 18-25 Septembre, 1981.
Beylot, C., Bioulac, P. Essai therapeutique d’un
angioprotecteur peripherique, l’Endotelon. Actualite Therapeutique Gaz. Med.
de France (87)22:2919-24, 1980.
Lesbre, F.X., Tigaud, J.D. Effect de l’Endotelon
sur l’indice de fragilite capillaire dan une population specifique: les sujets
cirrhotiques. Gaz. Med. de France, (90)24 1983.
Sarrat, L. Abord therapeutique
des troubles fonctionnels des membres inferieurs par un microangioprotecteur l’Endotelon.
Bordeaux Med, 11:685-8, 1981.
Delacroix, P. Etude en double aveugle de l’Endotelon
dans l’insuffisance veineuse chronique. Therapeutique, la Revue de Medicine,
(27-28) Sept. 1981. pp. 1793-1802.
Thebaut, J.F, Thebaut, P., Vin, F. Etude
de l’Endotelon dand les manifestations fonctionnelles de l’insuffisance
veineuse peripherique-resultats d’une etude en double aveugle portant sur
92 patients.” Gazette Medicale, (92)1, 1985. pp. 96-100.
Chang, W.C.,
Hsu, F.L. Inhibition of platelet aggregation and arachidonate metabolism in platelets
by procyanidins. Prostagland Leukotri Essent Fatty Acids, 38:181-8, 1989.
Masquelier, J. Pycnogenols: recent advances in the therapeutical activity of procyanidins.
Supplement of Planta Medica, Journal of Medicinal Plant Research and Journal of
Natural Products, July 1980 pp. 243-256.
Henning, B., et al. Lipid peroxidation
and endothelial cell injury: implications in atherosclerosis. Free Rad Path &
Med, (4)1988 pp. 99-106.
Masquelier, J. “Les procyanidols du vin leur
role dans l’alcoolisme.” pp. 88-93.
Gazave, J.M. “Notions recentes
sur les capillaires” unpub. bulletin from the Laboratoire De Physiologie
Patholigie pp. 26-29.
Ruf, J.C. Wine and polyphenols related to platelet aggregation
and atherothrombosis. Office International Vigne et du Vin, Nutrition and Health
Unit, Paris France; Drugs under Experimental and Clinical Research (Switz.) 25/2-3
(125-131), 1999.
Blaszo, G. Gabor, M. Oedema-inhibiting effect of procyanidin.
Acta Physiologica Academiae Scientiarum Hungaricae, Tomus 56(2):235-240, 1980.
Tayau, M.F, LeFevre, G. Action du leucocyanidol sur l’hyalaluronidase. Bull
Soc Pharm Bordeaux, 95:132-136, 1956.
Lamy, M. Utilization des oligomeres
procyanidoliques en gynecologie. Essai Therapeutique Tomel (14) Sept. 2, 1981.
pp. 1021-22.
Henriet, J.P “Une Etude Exemplaire Pour Un Phlebotrope:
l’etude EIVE.’ Unpub., pp. 77-83.
Pfister, A., Simon, M.T., Gazave,
J.M. Sites de fixation des oligomeres procyanidoliques dans la paroi des capillaires
sanguins du poumon decobaye. Acta Therapeutica (8) 1982. pp. 223-237.
Kuttan,
R., Donnelly, P., Di Ferrante, N. “Collagen treated with (+) -catechin becomes
resistant to the action of mammalian collagenase.” Laboratory of Connective
Tissue Research, Dept. of Biochem. Baylor Col. of Med., Houston TX. 28, May, 1980.
Gendre, P., Laparra, J., Barraud, E. “Effect protecteur des oligomeres procyanidoliques
sur le lathyrisme experimental chez le rat.” Ann. Pharm. Francaises, (43)1,
1985 pp. 61-73.
Corbe, C., Boissin, J.P., Siou, A. Light vision and chorioretinal
circulation. Study of the effect of procyanidolic oligomer (Endotelon). Jn. Fr.
Opthalmol, (11)5:453-460, 1988.
Boissin, J.P., Corbe C., Siou, A. Chorioretinal
circulation and dazzling: use of procyanidol oligomers (Endotelon). Bull Soc Ophtalmol
Fr, 88(2):173-4, 177-9, 1988.
Proto, F. et al. Electrophysical study of vitis
vinifera procyanoside oligomers effects on retinal function in myopic subjects.
Ann Ott Clin Ocul, 114:85-93, 1988.
Saracco, J.B., Estachy, G.M. Etude d l’Endotelon
en opthalmologie. Gaz Med de France, 88:2035-2038, 1981.
Scharrer, A., Ober,
M. Anthocyanosides in the treatment of retinopathies. Klin Monatsbl Augenheilkd,
178:386-389, 1981.
Corbe, C., et al. Microangiopathy of the retina. J. Fr.
Opthalmol, 11:453, 1988.
Verin, M.M., Vildy, A., Maurin, J.F., Retinopathies
et O.P.C. Bordeaux Medicale, (16)11. pp. 1467-74, 1978.
Soyeux, A. et al.
Endotelon. Diabetic retinopathy and hemorheology. Bull Soc Ophtalmol Fr. 87(12):1441-4,
1987.
Fromantin, M. “Les oligomeres procyanidoliques dans le traitement
de la fragilite capillaire et de la retinopathie chez les diabetiques. A propos
de 26 cas.” Med Int, 16(11):432-434, Nov. 1981.
Arne, J.L. Contribution
a l’etude des oligomeres procyanidoliques: Endotelon, dans la retinopathie
diabetique (a propos de 30 observations). Gaz. Med. de France, Vol. 89, No. 30,
Oct. 8, 1982.
Baruch, J. Effect of Endotelon in postoperative edema. Results
of a double-blind study versus placebo in 32 female patients. Ann Chir Plast Esthet
29(4):393-5, 1984.
Rao, C.N. et al. Influence of bioflavonoids on the collagen
metabolism in rats with adjuvantinduced arthritis. Ital J Biochem. 30:54-62, 1981.
Gabor, M. Pharmacologic effects of flavonoids on blood vessels. Angiologica, 9:355-374,
1972.
Havsteen, B. Flavonoids, a class of natural products of high pharmacological
potency. Biochem Pharmacol, 32:1141-48, 1983.
Reimann, H.J., Lorenz, W., Fischer,
M., Frölich, R., Meyer, H.J. Berkhauser Verlag, Vol. 7/1, Univ. of Marburg/Lahn,
Ger., 1977.
Masquelier, J. Action protectrice du vin sur l’ulcere gastrique.
Resultats, p. 61.
Amella, M., et al. Inhibition of mast cell histamine release
by flavonoids and bioflavonoids. Planta Medica, 5116-20, 1985.
Packer, L.,
et al. The antioxidant miracle: your complete plan. John Wiley & Sons, Inc.,
1999.
Shaw, R. How [Australian] PycnoGenol [MASQUELIER’s®] Helps
Sports People.
Masquelier, J. Procyanidolic oligomers (leucocyanidins). Parfums
Cosmet Arom 95:89-97, 1990.
Pecking, A., Desprez-Curely, J.P., Megret, G.
Oligomers procyanidoliques (Endotelon) dans le traitement des lymphoedemes post-therepeutiques
de members superieurs. Symposium Satellite, Congres International d’Angiologie,
Toulouse, France, 4-7 Oct. 1989.
Fahey, T.D., Pearl M. Hormonal effects of
phosphatidylserine during 2 weeks of intense training. Abstract submitted to national
meeting of the Amer College of Sports Medicine, June 1998.
Monteleone, P.,
Maj, M., Beinat, L., Natale, M., Kemali, D. Blunting by chronic phosphatidylserine
administration of the stress-induced activation of the hypothalamo-pituitary-adrenal
axis in healthy men. Eur J Clin Pharm 43: 385–388, 1992.
Fahey, T.D.,
et al. The hormonal and perceptive effects of phosphatidylserine administration
during two weeks of resistive exercise-induced overtraining. Bio of Sport 15(3):135-44,
1998.
Laparra, J., Michaud, J. Masquelier, J. Action des oligomeres procyanidoliques
sur le cobaye carence en vitamin c. Tavaux Originaux, University of Bordeaux,
1976.
Masquelier, J. Action comparee de divers facteurs vitaminiques p sur
l’oxydation de l’acide ascorbique par les ions cuivriques. Bull. de
la Societe de Chimie Biologique XXXIII (3-4) 1951. pp. 302-304.
Masquelier,
J. Action comparee de divers facteurs vitaminiques p sur l’acide ascorbique-oxydase.
Bull. de la Societe de Chimie Biologique XXXIII (3,4) 1951. pp.304-306
Kakegawa,
H., Matsumoto, H., Endo, K., Satoh, T., Nonaka, G., Mishioka, I. “Inhibitory
effects of tannins on hyaluronidase activation and on the degranulation from rat
mesentery mast cells.” Chem. Pharm. Bull. 33(11)1985. 5079-5082.
Reiman,
H.J., Lorenz, M., Fischer, R., Frolich, H., Meyer, J. “Histamine and acute
haemorrhagic lesions in rat gastric mucosa: prevention of stress ulcer formulation
by (+)-catechin, an inhibitor of specific histidine decarboxylase in vitro.”
Dirkhauser Verlag,Vol. 7/1, 1977.
Pariente, J.J. Parientl-Amsellem, J. “Les
oedemes post-traumatoqies chez le sportif: essai controle de l’Endothelon.”
Actualite Therapeutique 90(3) 2/11 1983 pp. 231-235.
Masquelier, J., et al.
“Flavonoids et Pycnogenols” Int J Vit Nut Res, (49)3:307-311, 1979.
Dumon, M., Michaud, J., Masquelier, J. Proanthocyanidin content in vegetable extracts
to be used in the preparation of medicines. Bull. Soc. Pharm. Bordeaux, 129:51-65,
1990.
This
incredible polyphenol complex from France 
and
seeds from 
Dr.
Masquelier's unequaled manufacturing process has been conducted for half a century
at the very same facilities in France, and under the control of French Pharmaceutical
inspection. These time-proven standards serve as a reliable assurance of the quality,
consistency, bioavailability and safety of FlavayT. 
